The president of Johnson & Johnson’s McNeil Consumer Healthcare recommended the “phantom recall” of defective Motrin tablets to get them off store shelves without notifying regulators or consumers. In an email obtained by the news organization, Peter Luther told his employees to start a “market withdraw of Motrin,” and asked them to “make this happen ASAP.”
The House Committee on Oversight and Government Reform started an investigation into McNeil after an April 30 recall of defective children’s medicines. Earlier this month, the committee sent letters requesting information to two contractors the panel believed were hired to buy the defective medicine from stores. Johnson & Johnson’s consumer group chairman Colleen Goggins said in a hearing before the committee that the company did not intend to mislead anyone.
According to Bloomberg, an email from May of 2009 also showed that Luther was concerned about how much to pay the contractors. “Given our current financial situation, I hope we’re not going to really double our cost to do this.”
Bloomberg said it received the emails from a source close to the investigation.
A spokeswoman for McNeil declined to comment.


